13-27924562-TGCCGCC-TGCCGCCGCC
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PM4_SupportingBP6BA1
The NM_000209.4(PDX1):c.726_728dup(p.Pro243dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0045 in 1,533,962 control chromosomes in the GnomAD database, including 253 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.025 ( 150 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 103 hom. )
Consequence
PDX1
NM_000209.4 inframe_insertion
NM_000209.4 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.781
Genes affected
PDX1 (HGNC:6107): (pancreatic and duodenal homeobox 1) The protein encoded by this gene is a transcriptional activator of several genes, including insulin, somatostatin, glucokinase, islet amyloid polypeptide, and glucose transporter type 2. The encoded nuclear protein is involved in the early development of the pancreas and plays a major role in glucose-dependent regulation of insulin gene expression. Defects in this gene are a cause of pancreatic agenesis, which can lead to early-onset insulin-dependent diabetes mellitus (IDDM), as well as maturity onset diabetes of the young type 4 (MODY4). [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_000209.4. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 13-27924562-T-TGCC is Benign according to our data. Variant chr13-27924562-T-TGCC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 36412.We mark this variant Likely_benign, oryginal submissions are: {Benign=9, Uncertain_significance=1}.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.083 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDX1 | NM_000209.4 | c.726_728dup | p.Pro243dup | inframe_insertion | 2/2 | ENST00000381033.5 | NP_000200.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDX1 | ENST00000381033.5 | c.726_728dup | p.Pro243dup | inframe_insertion | 2/2 | 1 | NM_000209.4 | ENSP00000370421 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0250 AC: 3802AN: 152032Hom.: 152 Cov.: 32
GnomAD3 genomes
AF:
AC:
3802
AN:
152032
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00234 AC: 301AN: 128404Hom.: 9 AF XY: 0.00198 AC XY: 142AN XY: 71672
GnomAD3 exomes
AF:
AC:
301
AN:
128404
Hom.:
AF XY:
AC XY:
142
AN XY:
71672
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00223 AC: 3088AN: 1381824Hom.: 103 Cov.: 31 AF XY: 0.00197 AC XY: 1346AN XY: 682232
GnomAD4 exome
AF:
AC:
3088
AN:
1381824
Hom.:
Cov.:
31
AF XY:
AC XY:
1346
AN XY:
682232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0250 AC: 3809AN: 152138Hom.: 150 Cov.: 32 AF XY: 0.0241 AC XY: 1789AN XY: 74380
GnomAD4 genome
AF:
AC:
3809
AN:
152138
Hom.:
Cov.:
32
AF XY:
AC XY:
1789
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
8
AN:
3460
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 06, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 10, 2019 | This variant is associated with the following publications: (PMID: 16229747, 17003361, 14764823, 10545531, 27634015) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 10, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 25, 2015 | - - |
Maturity-onset diabetes of the young type 4 Benign:2
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 18, 2011 | - - |
Neonatal diabetes mellitus Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing;curation | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 18, 2011 | - - |
Maturity onset diabetes mellitus in young Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 18, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Dec 07, 2018 | ACMG criteria: BP4 (CADD and indel predictor PROVEAN calls neutral, DDIG-indel 90% probability that it is neurtal), BA1 (7.5% in African and 38 homo in gnomAD), PM4 (nonframeshift protein length changing), PS3 (decrease in insulin promoter activity, PMID: 10545531), PP1mod (2 familes with 5 individuals each segregating, PMID: 10545531- 1999 paper, only looked at PDX1 variant)--> conflicting data BUT 7.5% in African --> BA1= benign - |
Diabetes mellitus type 2, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Nov 01, 1999 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at